S0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma

NCT00770224 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

87

Enrollment

NETWORK

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: rituximab
BIOLOGICAL: tositumomab
DRUG: cyclophosphamide
DRUG: doxorubicin
DRUG: prednisone
DRUG: vincristine
RADIATION: tositumomab

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]